4Weaver W, Copass M, Buff D, et al. Improved neurologic recovery and survival after early defibrillation. Circulation, 1984,69: 943 -948.
5American Heart Association. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 2000, 102(supl 1) : 1-384.
6Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of hospital cardiac arrest due to ventricular fibrillation. N Engl J Med, 1999, 341: 871-878.
7Cheng J, Kamiya K, Kodama I, et al. Differential effects of MS- 551 and E-4031 on action potentials and the delayed rectifier K ^+ current in rabbit ventricular myocytes. Cardiovasc Res,1996, 31 : 963 -974.
8Tanabe T, Iwamoto T, Iwata O, et al. Electrophysiologic and blood-flow responses in the endocardium and epicardium to disopyramide and MS-551 during myocardial ischemia in the dog. J Cardiovasc Pharmacol,1999, 34 : 275-286.
9Isomoto S, Konoe A, Centurion OA, et al. Electrophysiological effects of MS-551 in humans: a class Ⅲ antiarrhythmic agent. PACE, 1995, 18 : 2022-2027.
10Fredrichs G, Chi L, Gralinski M, et al. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death. J Cardiovasc Pharmacol,1995, 25: 314-323.
